GlassScriptPhysician profile
Steve K Mashour
NPI 1821075573
$11,606.17
in general payments reported to CMS, 2019-2025
48 companies · $2,408 in 2025
The $2,408 reported for 2025 was more than what 79% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,650 · 2020: $1,057 · 2021: $1,288 · 2022: $1,760 · 2023: $1,740 · 2024: $1,703 · 2025: $2,408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,769 · Education: $81.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,769.45 |
| Education | $81.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,916.66 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,644.04 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,041.42 | 2019-2025 | Ofev, Jascayd |
| Regeneron Healthcare Solutions, INC. | $953.01 | 2019-2025 | Dupixent |
| Genzyme Corporation | $512.96 | 2019-2025 | |
| United Therapeutics Corporation | $332.89 | 2019-2025 | Tyvaso, Tyvaso |
| Baxter Healthcare | $328.29 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Insmed, INC. | $315.06 | 2020-2025 | Arikayce, Brinsupri |
| Harmony Biosciences LLC | $285.13 | 2022-2024 | Wakix |
| Mylan Specialty L.P. | $257.82 | 2019-2024 | Yupelri |
| Pfizer INC. | $227.89 | 2019-2024 | |
| Mallinckrodt Hospital Products INC. | $226.25 | 2021-2022 | |
| Axsome Therapeutics, INC. | $207.72 | 2023-2025 | Sunosi |
| Verona Pharma, INC. | $171.48 | 2025 | Ohtuvayre |
| Advanced Respiratory, INC | $158.64 | 2019-2021 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Mashour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.